Dale Lincoln Ludwig

1 Patent

• US119127802024

  Anti-cd45-based Conditioning Methods and Uses Thereof in Conjunction with Gene-edited Cell-based Therapies

  ACTINIUM PHARMACEUTICALS, Inc.

  0 cites